Skip to content
OpenCapital
Get started

Chemed CHE Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies

HCA Healthcare logo
HCA HealthcareHCA
-$830M+44.5%

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's cash provided by (used in) financing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's cash provided by (used in) financing activity, including discontinued operation?
Chemed (CHE) reported cash provided by (used in) financing activity, including discontinued operation of -$108.09M in Q1 2026.
How has Chemed's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
Chemed's cash provided by (used in) financing activity, including discontinued operation decreased by 359.2% year-over-year, from -$23.54M to -$108.09M.
What is the long-term trend for Chemed's cash provided by (used in) financing activity, including discontinued operation?
Over 4 years (2021 to 2025), Chemed's cash provided by (used in) financing activity, including discontinued operation has grown at a 3.3% compound annual growth rate (CAGR), from -$380.62M to -$432.77M.
What does cash provided by (used in) financing activity, including discontinued operation mean?
This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.